JP2006502203A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502203A5
JP2006502203A5 JP2004542122A JP2004542122A JP2006502203A5 JP 2006502203 A5 JP2006502203 A5 JP 2006502203A5 JP 2004542122 A JP2004542122 A JP 2004542122A JP 2004542122 A JP2004542122 A JP 2004542122A JP 2006502203 A5 JP2006502203 A5 JP 2006502203A5
Authority
JP
Japan
Prior art keywords
troponin
phosphorylated
protein
translationally modified
serine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004542122A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006502203A (ja
Filing date
Publication date
Priority claimed from US10/270,838 external-priority patent/US7196169B2/en
Application filed filed Critical
Publication of JP2006502203A publication Critical patent/JP2006502203A/ja
Publication of JP2006502203A5 publication Critical patent/JP2006502203A5/ja
Withdrawn legal-status Critical Current

Links

JP2004542122A 2002-10-11 2003-10-10 筋肉損傷を監視し診断するための単離した翻訳後修飾タンパク質 Withdrawn JP2006502203A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/270,838 US7196169B2 (en) 2002-10-11 2002-10-11 Isolated post-translationally modified mammalian proteins for monitoring and diagnosing muscle damage
PCT/CA2003/001523 WO2004034060A2 (en) 2002-10-11 2003-10-10 Isolated post-translationally modified proteins for monitoring and diagnosing muscle damage

Publications (2)

Publication Number Publication Date
JP2006502203A JP2006502203A (ja) 2006-01-19
JP2006502203A5 true JP2006502203A5 (enExample) 2006-11-30

Family

ID=32069017

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004542122A Withdrawn JP2006502203A (ja) 2002-10-11 2003-10-10 筋肉損傷を監視し診断するための単離した翻訳後修飾タンパク質

Country Status (6)

Country Link
US (1) US7196169B2 (enExample)
EP (1) EP1554587A2 (enExample)
JP (1) JP2006502203A (enExample)
AU (1) AU2003273674A1 (enExample)
CA (1) CA2501756C (enExample)
WO (1) WO2004034060A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618782B1 (en) 1999-10-18 2009-11-17 Queen's University At Kingston Methods of diagnosing muscle damage
AU2001279313B2 (en) 2000-08-04 2007-03-01 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
CA2419295A1 (en) * 2000-08-21 2002-02-28 Queen's University At Kingston Methods and kits for separation and detection of proteins in biological samples
ATE520981T1 (de) 2002-10-02 2011-09-15 Dmi Biosciences Inc Diagnose und überwachung von krankheiten
CA3050734A1 (en) 2003-05-15 2004-12-02 Ampio Pharmaceuticals, Inc. Treatment of t-cell mediated diseases
ES2367311T3 (es) * 2004-04-15 2011-11-02 University Of Florida Research Foundation, Inc. Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales.
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
CA2667012A1 (en) * 2006-10-26 2008-05-02 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
CN1974594B (zh) * 2006-11-16 2010-04-14 中国人民解放军军事医学科学院卫生学环境医学研究所 人心肌肌钙蛋白ⅰ亚基核酸适配子及应用
JP5376370B2 (ja) 2007-06-20 2013-12-25 日本電気株式会社 肝細胞がんタンパク質マーカーとそれを用いた肝細胞がんの検出方法
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
EP3178846B1 (en) * 2010-02-17 2018-08-22 Cedars-Sinai Medical Center Novel phosphorylation of cardiac troponin i as a monitor for cardiac injury
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
EA027343B1 (ru) 2011-10-10 2017-07-31 Ампио Фармасьютикалз, Инк. Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования
EP2766029B1 (en) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
CA2846394A1 (en) 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
WO2013085367A1 (en) * 2011-12-09 2013-06-13 Kyungpook National University Industry-Academic Cooperation Foundation Cardiac troponin i-targeting peptide and use thereof
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
AU2015305611B2 (en) 2014-08-18 2020-04-23 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN111662909B (zh) * 2019-03-05 2022-07-15 中国科学技术大学 心肌肌钙蛋白i特异性核酸适配体及其应用
BR102021020613A2 (pt) * 2021-10-14 2023-04-18 Universidade Federal Do Rio De Janeiro Método de investigação proteômica em amostra para diagnóstico da rabdomiólise e kits para realização do mesmo

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994027156A1 (en) 1993-05-17 1994-11-24 Fortron Bioscience, Inc. Assay for cardiac troponin i
US5702905A (en) 1994-09-28 1997-12-30 Spectral Diagnostics Monoclonal antibody to human ventricular myosin light chains
US5795725A (en) 1995-04-18 1998-08-18 Biosite Diagnostics Incorporated Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays
US6227658B1 (en) 1997-06-23 2001-05-08 Kabushiki Kaisha Toshiba Apparatus and method for forming thin film using ink-jet mechanism
US7384751B1 (en) 1997-07-16 2008-06-10 Queen's University At Kingston Methods of diagnosing muscle damage
US6248546B1 (en) * 1998-03-09 2001-06-19 Diagnostic Systems Laboratories, Inc. Assay of IGFBP complex

Similar Documents

Publication Publication Date Title
ES2379104T3 (es) Métodos para evaluar el fallo cardíaco en pacientes con fibrilación auricular utilizando péptidos GDF-15
PH12020551371A1 (en) Assays to detect neurodegeneration
JP2010524432A5 (enExample)
JP2017215338A5 (enExample)
JP2018536849A5 (enExample)
JP2014529405A5 (enExample)
JP2005534344A5 (enExample)
JP2018529931A5 (enExample)
JP4689651B2 (ja) 急性肺塞栓症用生化学マーカー
ES2954321T3 (es) Proteína 3 de unión a ácidos grasos para la evaluación de fibrilación auricular (FA)
JP2006502203A (ja) 筋肉損傷を監視し診断するための単離した翻訳後修飾タンパク質
RU2019106326A (ru) Гистоны и/или proadm в качестве маркеров, свидетельствующих об органной дисфункции
JP2018536170A5 (enExample)
US20090148860A1 (en) Methods of diagnosing muscle damage
JP2008514209A5 (enExample)
JP2019510974A5 (enExample)
CN104714031A (zh) 一种心肌梗死快速检测试剂盒
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
RU2008103988A (ru) Способ диагностики рассеяного склероза
Zaninotto et al. New biochemical markers: from bench to bedside
Akalya et al. Elevated urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein-7 predict drug-induced acute kidney injury
JP2008547006A5 (enExample)
JP2010513917A (ja) ロングペントラキシンptx3の血漿レベルを測定するための方法
JP2007523640A5 (enExample)
ES2389022T3 (es) Mioglobina como predictor precoz del infarto de miocardio